Seungchul Han
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Seungchul Han has a total of 46 co-authors. Here are the top co-authors by number of shared publications:
- Dong Ho Lee
Department of Radiology, Seoul National University Hospital, Seoul National University College of Medicine
5 shared publications - Jae Hyun Kim
Department of Radiology, Seoul National University Hospital, Seoul, Korea
5 shared publications - Hyun Pyo Hong
Department of Radiology, Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine, Seoul, Korea
4 shared publications - Min Woo Lee
Department of Radiology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea
4 shared publications - Dong Jin Chung
Department of Radiology, Yeouido St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea
3 shared publications - Hyunchul Rhim
Department of Radiology and Center for Imaging Science, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea
3 shared publications
Latest Publications
- Open Access
- 1 September 2026
- Published by Korean Society of Ultrasound in Medicine in Ultrasonography
- Vol. 45 (5) , 491-502
Differentiating hepatic hemangiomas from hepatocellular carcinomas using Sonazoid-enhanced ultrasonography: a proposed two-step diagnostic algorithm
Purpose: This study aimed to develop a diagnostic algorithm for differentiating hepatic hemangiomas from hepatocellular carcinoma (HCC) using Sonazoid-enhanced ultrasonography (SEUS).Methods: A retrospective analysis was conducted of SEUS examinations from 159 patients with 110 hemangiomas and 49 HCCs between January 2011 and December 2022. The evaluated imaging features included lesion hyperechogenicity, typical grayscale features of hemangioma, defined as a hyperechoic lesion or echogenic border without a hypoechoic rim or nodule-in-nodule appearance, and typical globular enhancement of hemangioma. In the Kupffer phase (KP), the lesion-to-liver ratio (KP ratio) was calculated, and receiver operating characteristic analysis was performed to determine the optimal KP ratio cutoff for predicting hemangioma. A two-step diagnostic algorithm was developed and compared with typical globular enhancement of hemangioma using the McNemar test.Results: The optimal KP ratio cutoff for predicting hemangioma was 0.85. The two-step algorithm first identified hemangiomas based on typical globular enhancement and then applied typical grayscale features and a KP ratio ≥0.85 to lesions without typical globular enhancement. The algorithm showed higher sensitivity than typical globular enhancement alone (90.0% vs. 81.8%, P=0.008) while maintaining 100% specificity. In hyperechoic lesions, the algorithm also showed higher sensitivity than typical globular enhancement alone (91.9% vs. 77.4%, P=0.008).Conclusion: The proposed two-step algorithm may improve sensitivity while maintaining specificity in clinical settings that require differentiation between hemangiomas and HCC.
- 1 September 2026
- Published by Korean Society of Ultrasound in Medicine in Ultrasonography
- Vol. 45 (5) , 491-502
Open AccessDifferentiating hepatic hemangiomas from hepatocellular carcinomas using Sonazoid-enhanced ultrasonography: a proposed two-step diagnostic algorithm
Purpose: This study aimed to develop a diagnostic algorithm for differentiating hepatic hemangiomas from hepatocellular carcinoma (HCC) using Sonazoid-enhanced ultrasonography (SEUS).Methods: A retrospective analysis was conducted of SEUS examinations from 159 patients with 110 hemangiomas and 49 HCCs between January 2011 and December 2022. The evaluated imaging features included lesion hyperechogenicity, typical grayscale features of hemangioma, defined as a hyperechoic lesion or echogenic border without a hypoechoic rim or nodule-in-nodule appearance, and typical globular enhancement of hemangioma. In the Kupffer phase (KP), the lesion-to-liver ratio (KP ratio) was calculated, and receiver operating characteristic analysis was performed to determine the optimal KP ratio cutoff for predicting hemangioma. A two-step diagnostic algorithm was developed and compared with typical globular enhancement of hemangioma using the McNemar test.Results: The optimal KP ratio cutoff for predicting hemangioma was 0.85. The two-step algorithm first identified hemangiomas based on typical globular enhancement and then applied typical grayscale features and a KP ratio ≥0.85 to lesions without typical globular enhancement. The algorithm showed higher sensitivity than typical globular enhancement alone (90.0% vs. 81.8%, P=0.008) while maintaining 100% specificity. In hyperechoic lesions, the algorithm also showed higher sensitivity than typical globular enhancement alone (91.9% vs. 77.4%, P=0.008).Conclusion: The proposed two-step algorithm may improve sensitivity while maintaining specificity in clinical settings that require differentiation between hemangiomas and HCC.
- Open Access
- 1 March 2026
- Published by Korean Society of Ultrasound in Medicine in Ultrasonography
- Vol. 45 (2) , 95-106
Ultrasound-guided ablation of hepatocellular carcinoma: a review of its past, present, and future
Ultrasound (US)-guided ablation has evolved from early ethanol injection into a cornerstone curative strategy for hepatocellular carcinoma. This review traces the technological advancement of US guidance from early pioneering efforts to present standardized techniques and future innovations. It discusses how modern tools—fusion imaging, contrast-enhanced US, and artificial fluid techniques—overcome challenges in tumor visibility and accessibility, emphasizing technique optimization rather than energy modality selection. The review also explores future horizons, including artificial intelligence–driven planning, histotripsy, and immuno-ablation. Ultimately, the authors advocate for a philosophy of “optimized ablation,” prioritizing technical mastery of evolving US technologies to maximize therapeutic efficacy and patient safety beyond simple expansion of treatment territory.
- 1 March 2026
- Published by Korean Society of Ultrasound in Medicine in Ultrasonography
- Vol. 45 (2) , 95-106
Open AccessUltrasound-guided ablation of hepatocellular carcinoma: a review of its past, present, and future
Ultrasound (US)-guided ablation has evolved from early ethanol injection into a cornerstone curative strategy for hepatocellular carcinoma. This review traces the technological advancement of US guidance from early pioneering efforts to present standardized techniques and future innovations. It discusses how modern tools—fusion imaging, contrast-enhanced US, and artificial fluid techniques—overcome challenges in tumor visibility and accessibility, emphasizing technique optimization rather than energy modality selection. The review also explores future horizons, including artificial intelligence–driven planning, histotripsy, and immuno-ablation. Ultimately, the authors advocate for a philosophy of “optimized ablation,” prioritizing technical mastery of evolving US technologies to maximize therapeutic efficacy and patient safety beyond simple expansion of treatment territory.
- Open Access
- 1 January 2026
- Published by XMLink in Korean Journal of Radiology
- Vol. 27 (4) , 332-343
Ultrasound Imaging Features Associated With Neoplastic Gallbladder Polyps: A Systematic Review and Meta-Analysis
Lee S, et al. Korean J Radiol. 2026 ;27:e20. https://doi.org/10.3348/kjr.2025.1126
- 1 January 2026
- Published by XMLink in Korean Journal of Radiology
- Vol. 27 (4) , 332-343
Open AccessUltrasound Imaging Features Associated With Neoplastic Gallbladder Polyps: A Systematic Review and Meta-Analysis
Lee S, et al. Korean J Radiol. 2026 ;27:e20. https://doi.org/10.3348/kjr.2025.1126
- Open Access
- 1 September 2025
- Published by Korean Society of Ultrasound in Medicine in Ultrasonography
- Vol. 44 (5) , 354-362
Impact of an immediate short waiting period on ultrasound-based ablative margin assessment following radiofrequency ablation for hepatocellular carcinoma
Purpose: This study aimed to evaluate whether an immediate short waiting period after radiofrequency ablation (RFA) can improve the accuracy of ultrasound (US)-based assessment of the ablation zone in patients with hepatocellular carcinoma (HCC).Methods: A prospective cohort study was conducted involving 41 patients who underwent US-guided RFA for HCC. Tumor margin conspicuity, electrode tip visibility, and operator confidence in assessing the ablative margin were recorded immediately following electrode deactivation and at 1-minute intervals for 5 minutes. Post-ablation computed tomography was performed to confirm the sufficiency of the ablative margins. The Friedman test and post-hoc Conover analysis were used to assess changes over time.Results: Over time, significant improvements were observed in tumor margin visibility, electrode tip visualization, and operator confidence in ablative margin assessment (all P<0.001). Repositioning and additional ablation were required in 29.3% (12/41) of patients, with all achieving sufficient ablative margins. Larger tumor size was associated with decreased operator confidence (P=0.008). No major complications occurred.Conclusion: A short waiting period following RFA enhances the visibility of tumor margins and electrode tips on US, thereby increasing operator confidence in assessing ablative margin sufficiency. Implementing an immediate short waiting period may improve the accuracy of treatment.
- 1 September 2025
- Published by Korean Society of Ultrasound in Medicine in Ultrasonography
- Vol. 44 (5) , 354-362
Open AccessImpact of an immediate short waiting period on ultrasound-based ablative margin assessment following radiofrequency ablation for hepatocellular carcinoma
Purpose: This study aimed to evaluate whether an immediate short waiting period after radiofrequency ablation (RFA) can improve the accuracy of ultrasound (US)-based assessment of the ablation zone in patients with hepatocellular carcinoma (HCC).Methods: A prospective cohort study was conducted involving 41 patients who underwent US-guided RFA for HCC. Tumor margin conspicuity, electrode tip visibility, and operator confidence in assessing the ablative margin were recorded immediately following electrode deactivation and at 1-minute intervals for 5 minutes. Post-ablation computed tomography was performed to confirm the sufficiency of the ablative margins. The Friedman test and post-hoc Conover analysis were used to assess changes over time.Results: Over time, significant improvements were observed in tumor margin visibility, electrode tip visualization, and operator confidence in ablative margin assessment (all P<0.001). Repositioning and additional ablation were required in 29.3% (12/41) of patients, with all achieving sufficient ablative margins. Larger tumor size was associated with decreased operator confidence (P=0.008). No major complications occurred.Conclusion: A short waiting period following RFA enhances the visibility of tumor margins and electrode tips on US, thereby increasing operator confidence in assessing ablative margin sufficiency. Implementing an immediate short waiting period may improve the accuracy of treatment.
- Open Access
- 1 January 2025
- Published by XMLink in Korean Journal of Radiology
- Vol. 26 (2) , 102-134
Interpretation, Reporting, Imaging-Based Workups, and Surveillance of Incidentally Detected Gallbladder Polyps and Gallbladder Wall Thickening: 2025 Recommendations From the Korean Society of Abdominal Radiology
Chang W, et al. Korean J Radiol. 2025 Feb;26(2):102-134. https://doi.org/10.3348/kjr.2024.0914
- 1 January 2025
- Published by XMLink in Korean Journal of Radiology
- Vol. 26 (2) , 102-134
Open AccessInterpretation, Reporting, Imaging-Based Workups, and Surveillance of Incidentally Detected Gallbladder Polyps and Gallbladder Wall Thickening: 2025 Recommendations From the Korean Society of Abdominal Radiology
Chang W, et al. Korean J Radiol. 2025 Feb;26(2):102-134. https://doi.org/10.3348/kjr.2024.0914
- Open Access
- 30 September 2024
- Published by Korean Liver Cancer Association in Journal of Liver Cancer
- Vol. 24 (2) , 131-144
Local ablation for hepatocellular carcinoma: 2024 expert consensus-based practical recommendation of the Korean Liver Cancer Association
Local ablation for hepatocellular carcinoma (HCC), a non-surgical option that directly targets and destroys tumor cells, has advanced significantly since the 1990s. Therapies with different energy sources, such as radiofrequency ablation, microwave ablation, and cryoablation, employ different mechanisms to induce tumor necrosis. The precision, safety, and effectiveness of these therapies have increased with advances in guiding technologies and device improvements. Consequently, local ablation has become the firstline treatment for early-stage HCC. The lack of organized evidence and expert opinions regarding patient selection, pre-procedure preparation, procedural methods, swift post-treatment evaluation, and follow-up has resulted in clinicians following varied practices. Therefore, an expert consensus-based practical recommendation for local ablation was developed by a group of experts in radiology and hepatology from the Research Committee of the Korean Liver Cancer Association in collaboration with the Korean Society of Image-guided Tumor Ablation to provide useful information and guidance for performing local ablation and for the pre- and posttreatment management of patients.
- 30 September 2024
- Published by Korean Liver Cancer Association in Journal of Liver Cancer
- Vol. 24 (2) , 131-144
Open AccessLocal ablation for hepatocellular carcinoma: 2024 expert consensus-based practical recommendation of the Korean Liver Cancer Association
Local ablation for hepatocellular carcinoma (HCC), a non-surgical option that directly targets and destroys tumor cells, has advanced significantly since the 1990s. Therapies with different energy sources, such as radiofrequency ablation, microwave ablation, and cryoablation, employ different mechanisms to induce tumor necrosis. The precision, safety, and effectiveness of these therapies have increased with advances in guiding technologies and device improvements. Consequently, local ablation has become the firstline treatment for early-stage HCC. The lack of organized evidence and expert opinions regarding patient selection, pre-procedure preparation, procedural methods, swift post-treatment evaluation, and follow-up has resulted in clinicians following varied practices. Therefore, an expert consensus-based practical recommendation for local ablation was developed by a group of experts in radiology and hepatology from the Research Committee of the Korean Liver Cancer Association in collaboration with the Korean Society of Image-guided Tumor Ablation to provide useful information and guidance for performing local ablation and for the pre- and posttreatment management of patients.
- Open Access
- 3 September 2024
- Published by The Editorial Office of Gut and Liver in Gut and Liver
- Vol. 18 (5) , 789-802
Local Ablation for Hepatocellular Carcinoma: 2024 Expert Consensus-Based Practical Recommendations of the Korean Liver Cancer Association
Seungchul Han, Pil Soo Sung, Soo Young Park, Jin Woong Kim, Hyun Pyo Hong, Jung-Hee Yoon, Dong Jin Chung, Joon Ho Kwon, Sanghyeok Lim, Jae Hyun Kim, Seung Kak Shin, Tae Hyung Kim, Dong Ho Lee, Jong Young Choi, Research Committee of the Korean Liver Cancer Association. Gut and Liver 2024;18:789-802. https://doi.org/10.5009/gnl240350
- 3 September 2024
- Published by The Editorial Office of Gut and Liver in Gut and Liver
- Vol. 18 (5) , 789-802
Open AccessLocal Ablation for Hepatocellular Carcinoma: 2024 Expert Consensus-Based Practical Recommendations of the Korean Liver Cancer Association
Seungchul Han, Pil Soo Sung, Soo Young Park, Jin Woong Kim, Hyun Pyo Hong, Jung-Hee Yoon, Dong Jin Chung, Joon Ho Kwon, Sanghyeok Lim, Jae Hyun Kim, Seung Kak Shin, Tae Hyung Kim, Dong Ho Lee, Jong Young Choi, Research Committee of the Korean Liver Cancer Association. Gut and Liver 2024;18:789-802. https://doi.org/10.5009/gnl240350
- Open Access
- 1 January 2024
- Published by XMLink in Korean Journal of Radiology
- Vol. 25 (9) , 773-787
Local Ablation for Hepatocellular Carcinoma: 2024 Expert Consensus-Based Practical Recommendations of the Korean Liver Cancer Association
Han S, et al. Korean J Radiol. 2024 Sep;25(9):773-787. https://doi.org/10.3348/kjr.2024.0550
- 1 January 2024
- Published by XMLink in Korean Journal of Radiology
- Vol. 25 (9) , 773-787
Open AccessLocal Ablation for Hepatocellular Carcinoma: 2024 Expert Consensus-Based Practical Recommendations of the Korean Liver Cancer Association
Han S, et al. Korean J Radiol. 2024 Sep;25(9):773-787. https://doi.org/10.3348/kjr.2024.0550
- Open Access
- 15 July 2023
- Published by The Korean Society of Abdominal Radiology in Korean Journal of Abdominal Radiology
- Vol. 7 (1) , 35-45
Can Perfusion CT Differentiate GIST from Other Benign Subepithelial Tumors in the Stomach?
Purpose: To evaluate the diagnostic performance of perfusion computed tomography (PCT) parameters for differentiating gastrointestinal stromal tumors (GISTs) from other benign subepithelial tumors (SETs) in the stomach.Materials and Methods: Thirty-one patients with gastric SETs subsequently confirmed via surgery underwent PCT using a multidetector computed tomography (CT) scanner at 80 kVp. Two radiologists analyzed key CT features including homogeneity and degree of enhancement. PCT parameters including blood flow, blood volume, mean transit time, and permeability surface value (PS) were independently calculated by two other radiologists. Comparative analysis of the CT features and perfusion parameters of GISTs and other benign SETs was then performed. Diagnostic performances of the perfusion parameters were also evaluated using receiver operating characteristic (ROC) analysis.Results: Twenty-four patients were proven to have GISTs via histologic examination, while the remaining non-GISTs included 3 leiomyomas, 3 schwannomas, and 1 totally necrotic nodule. Among the conventional CT features, lymphadenopathy was more frequent in non-GISTs (2/7, 28.6%) than in GISTs (0/24, 0%) (p = 0.045). Among the PCT parameters, the mean PS in the areas of strongest enhancement of GISTs (25.3 ± 23.9 mL/100 g/min) was significantly higher than that of other SETs (8.8 ± 8.8 mL/100 g/min) (p = 0.029). In ROC analysis, an area under the curve of 0.774 (p = 0.03), sensitivity of 91.7%, and specificity of 57.1% were achieved when the PS cut-off was set at 7.17 mL/100 g/min.Conclusions: Perfusion parameters were helpful for differentiating GISTs from other benign SETs, as GISTs exhibited significantly higher PS than non-GISTs.
- 15 July 2023
- Published by The Korean Society of Abdominal Radiology in Korean Journal of Abdominal Radiology
- Vol. 7 (1) , 35-45
Open AccessCan Perfusion CT Differentiate GIST from Other Benign Subepithelial Tumors in the Stomach?
Purpose: To evaluate the diagnostic performance of perfusion computed tomography (PCT) parameters for differentiating gastrointestinal stromal tumors (GISTs) from other benign subepithelial tumors (SETs) in the stomach.Materials and Methods: Thirty-one patients with gastric SETs subsequently confirmed via surgery underwent PCT using a multidetector computed tomography (CT) scanner at 80 kVp. Two radiologists analyzed key CT features including homogeneity and degree of enhancement. PCT parameters including blood flow, blood volume, mean transit time, and permeability surface value (PS) were independently calculated by two other radiologists. Comparative analysis of the CT features and perfusion parameters of GISTs and other benign SETs was then performed. Diagnostic performances of the perfusion parameters were also evaluated using receiver operating characteristic (ROC) analysis.Results: Twenty-four patients were proven to have GISTs via histologic examination, while the remaining non-GISTs included 3 leiomyomas, 3 schwannomas, and 1 totally necrotic nodule. Among the conventional CT features, lymphadenopathy was more frequent in non-GISTs (2/7, 28.6%) than in GISTs (0/24, 0%) (p = 0.045). Among the PCT parameters, the mean PS in the areas of strongest enhancement of GISTs (25.3 ± 23.9 mL/100 g/min) was significantly higher than that of other SETs (8.8 ± 8.8 mL/100 g/min) (p = 0.029). In ROC analysis, an area under the curve of 0.774 (p = 0.03), sensitivity of 91.7%, and specificity of 57.1% were achieved when the PS cut-off was set at 7.17 mL/100 g/min.Conclusions: Perfusion parameters were helpful for differentiating GISTs from other benign SETs, as GISTs exhibited significantly higher PS than non-GISTs.
- Open Access
- 1 January 2023
- Published by XMLink in Korean Journal of Radiology
- Vol. 24 (8) , 761-771
Treatment Outcomes of Percutaneous Radiofrequency Ablation for Hepatocellular Carcinomas: Effects of the Electrode Type and Placement Method
Park J, et al. Korean J Radiol. 2023 Aug;24(8):761-771. https://doi.org/10.3348/kjr.2023.0022
- 1 January 2023
- Published by XMLink in Korean Journal of Radiology
- Vol. 24 (8) , 761-771
Open AccessTreatment Outcomes of Percutaneous Radiofrequency Ablation for Hepatocellular Carcinomas: Effects of the Electrode Type and Placement Method
Park J, et al. Korean J Radiol. 2023 Aug;24(8):761-771. https://doi.org/10.3348/kjr.2023.0022